Your browser doesn't support javascript.
loading
Screening-based discovery of the first novel ATP competitive inhibitors of the Staphylococcus aureus essential enzyme UMP kinase.
Doig, Peter; Gorseth, Elise; Nash, Tory; Patten, Arthur; Gao, Ning; Blackett, Carolyn.
Afiliação
  • Doig P; Discovery Sciences, AstraZeneca R&D Boston, Waltham, MA 02451, United States. Peter.Doig@AstraZeneca.com
Biochem Biophys Res Commun ; 437(1): 162-7, 2013 Jul 19.
Article em En | MEDLINE | ID: mdl-23806686
UMP kinase (PyrH) is an essential enzyme found only in bacteria, making it ideal as a target for the discovery of antibacterials. To identify inhibitors of PyrH, an assay employing Staphylococcus aureus PyrH coupled to pyruvate kinase/lactate dehydrogenase was developed and was used to perform a high throughput screen. A validated aminopyrimidine series was identified from screening. Kinetic characterization of this aminopyrimidine indicated it was a competitive inhibitor of ATP. We have shown that HTS can be used to identify potential leads for this novel target, the first ATP competitive inhibitor of PyrH reported.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Staphylococcus aureus / Trifosfato de Adenosina / Núcleosídeo-Fosfato Quinase / Inibidores Enzimáticos Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Idioma: En Ano de publicação: 2013 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Staphylococcus aureus / Trifosfato de Adenosina / Núcleosídeo-Fosfato Quinase / Inibidores Enzimáticos Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Idioma: En Ano de publicação: 2013 Tipo de documento: Article